IPI-950

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIPI-950
Drug Alias NameTBC-10950IPI-950TBC-10667TBC-10894
ClassificationSmall molecules
Mechanisms of ActionEndothelin receptor type B antagonists
TargetsEndothelin receptor type B
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunoPharmaceutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunoPharmaceutics Inc
Active IndicationsN/A
Inactive IndicationsRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A